Canada markets closed

Phathom Pharmaceuticals, Inc. (PHAT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.18+0.08 (+0.88%)
At close: 04:00PM EDT
8.90 -0.28 (-3.05%)
After hours: 04:38PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 532.57M
Enterprise Value 290.21M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)684.36
Price/Book (mrq)N/A
Enterprise Value/Revenue 425.52
Enterprise Value/EBITDA -1.82

Trading Information

Stock Price History

Beta (5Y Monthly) 0.63
52-Week Change 3-14.95%
S&P500 52-Week Change 321.08%
52 Week High 317.02
52 Week Low 36.07
50-Day Moving Average 39.72
200-Day Moving Average 310.17

Share Statistics

Avg Vol (3 month) 3888.34k
Avg Vol (10 day) 3564.02k
Shares Outstanding 558.52M
Implied Shares Outstanding 658.52M
Float 843.23M
% Held by Insiders 18.92%
% Held by Institutions 188.58%
Shares Short (Apr 15, 2024) 412.03M
Short Ratio (Apr 15, 2024) 413.35
Short % of Float (Apr 15, 2024) 442.24%
Short % of Shares Outstanding (Apr 15, 2024) 420.56%
Shares Short (prior month Mar 15, 2024) 410.44M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-10,245.60%

Management Effectiveness

Return on Assets (ttm)-36.14%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)682k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -166.74M
Net Income Avi to Common (ttm)-201.59M
Diluted EPS (ttm)-3.93
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)381.39M
Total Cash Per Share (mrq)6.52
Total Debt (mrq)445.96M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)10.25
Book Value Per Share (mrq)-1.25

Cash Flow Statement

Operating Cash Flow (ttm)-137.58M
Levered Free Cash Flow (ttm)-90.45M